Css LLC Kal Vista Pharmaceuticals, Inc. Call Options Transaction History

Css LLC

7 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2022 Feb 14, 2023	BUY	$4.2 - $14.24 $80,640 - $273,408	19,200 Added 68.33%	47,300 $319,000
Q2 2022 Aug 15, 2022	BUY	$8.16 - $15.1 $219,504 - $406,190	26,900 Added 2241.67%	28,100 $277,000
Q1 2022 May 16, 2022	SELL	$11.2 - $16.97 $125,439 - $190,064	-11,200 Reduced 90.32%	1,200 $18,000
Q4 2021 Feb 14, 2022	SELL	$12.36 - $18.28 $112,476 - $166,348	-9,100 Reduced 42.33%	12,400 $164,000
Q2 2021 Aug 16, 2021	SELL	$23.12 - $29.91 $252,008 - $326,019	-10,900 Reduced 33.64%	21,500 $515,000
Q1 2021 May 17, 2021	BUY	$14.69 - $42.57 $373,126 - $1.08 Million	25,400 Added 362.86%	32,400 $833,000
Q4 2020 Feb 16, 2021	BUY	$12.88 - $19.47 $90,160 - $136,290	7,000 New	7,000 $133,000

125

47.8M

551K

110K

Ticker KALV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 24,602,000
Market Cap $250M
Description
KalVista Pharmaceuticals, Inc., a clinical stage pharmaceutical company, discovers, develops, and commercializes small molecule protease inhibitors for diseases with unmet needs. The company's product portfolio comprises small molecule plasma kallikrein inhibitors targeting hereditary angioedema (HAE) and diabetic macular edema (DME); and oral p...

Get notified when there are updates to the investment portfolio of Css LLC, based on Form 13F filings with the SEC.

Stay updated on Css LLC with notifications on news.